How to Save Money on Mavyret in 2026: Coupons, Discounts, and Patient Assistance

Mavyret (glecaprevir/pibrentasvir) is one of the most effective medicines ever developed for any disease—an 8-week oral cure for hepatitis C. It's also one of the most expensive. An 8-week supply (84 tablets) carries a retail price tag between $14,000 and $17,000. Most patients cannot and should not pay that amount. Here's a comprehensive guide to every program and strategy that can reduce your Mavyret costs in 2026.

How Much Does Mavyret Cost?

Here's a quick breakdown of Mavyret costs in different scenarios:

Cash/retail price: $14,101–$16,901 for 84 tablets (8-week supply)

With SingleCare discount: approximately $12,900 at participating pharmacies

With commercial insurance + AbbVie savings card: as low as $5 per month

Medicare Part D + Low Income Subsidy: approximately $12.15 per month in 2025

With myAbbVie Assist (uninsured): potentially $0 for eligible patients

Option 1: AbbVie Mavyret Savings Card (For Commercially Insured Patients)

If you have commercial (employer or marketplace) insurance, the Mavyret Savings Card from AbbVie is your best first move. Eligible patients pay as little as $5 per prescription, with a lifetime maximum savings of up to $12,000.

Important restrictions: This program is for commercially insured patients only. It is NOT available for patients with Medicare, Medicaid, or other government-funded insurance.

How to get it: Visit mavyret.com/cost or call 1-877-628-9738. You can download and print the card, or receive it digitally.

Option 2: myAbbVie Assist (For Uninsured or Underinsured Patients)

For patients who have no insurance or cannot afford their out-of-pocket costs, AbbVie's myAbbVie Assist patient assistance program may provide Mavyret at no cost. Eligibility is based on financial need and residency status.

How to apply: Call 1-800-222-6885 or visit AbbVie.com/PatientAccessSupport. Have your income information and prescription ready. Your doctor may also be able to initiate this on your behalf.

Option 3: Medicare Coverage and Part D

Mavyret is covered by Medicare Part D, but it is not covered by most plans without prior authorization. Once approved, your cost depends on your specific plan's formulary tier and deductible. In 2026, the Medicare Part D out-of-pocket maximum is $2,100—after you reach that cap, your plan pays 100% for covered medications for the rest of the year.

If you qualify for Medicare's Low Income Subsidy (Extra Help), your out-of-pocket costs for Mavyret were approximately $12.15 per month in 2025. Contact Social Security at 1-800-772-1213 or visit ssa.gov to apply for Extra Help if you have limited income.

Note: AbbVie's savings card cannot be used with Medicare. For Medicare patients, foundation assistance programs are the primary resource.

Option 4: Foundation Assistance Programs

Several independent foundations provide financial assistance for hepatitis C medications including Mavyret:

HealthWell Foundation Hepatitis C Fund: Helps patients with insurance cover cost-sharing. Call 1-800-675-8416 or visit healthwellfoundation.org/fund/hepatitis-c/. Pediatric assistance also available.

Good Days Patient Assistance Program: Requires insurance and a valid prescription. Call 1-877-968-7233 or visit mygooddays.org.

Patient Advocate Foundation Co-Pay Relief: Provides co-pay assistance for eligible patients with government or commercial insurance. Visit patientadvocate.org.

Option 5: Medicaid Coverage

Medicaid is required to cover nearly all FDA-approved drugs for their approved indications, including Mavyret. If you're on Medicaid and have been prescribed Mavyret, your cost should be minimal or zero. Some states have historically placed restrictions on hepatitis C treatment coverage (like requiring a certain stage of liver disease), but these restrictions have largely been removed due to legal challenges and policy changes. If your Medicaid plan is creating barriers, contact a patient advocate or legal aid organization.

Option 6: Should You Consider a Generic Alternative?

There is no generic version of Mavyret. If cost is your primary barrier and you're not eligible for assistance programs, ask your doctor whether generic sofosbuvir/velpatasvir (the generic form of Epclusa) is clinically appropriate for you. It's available at dramatically lower prices and is also an effective, pangenotypic hepatitis C treatment, though treatment duration is 12 weeks rather than 8.

How medfinder Helps You Start Treatment Sooner

Once you've secured financial coverage for Mavyret, the next challenge is finding a pharmacy that has it. medfinder contacts pharmacies near you to identify who has Mavyret in stock and can fill your prescription. You can also read our full article on the Mavyret shortage and patient access in 2026.